<DOC>
	<DOCNO>NCT00387829</DOCNO>
	<brief_summary>To evaluate safety effectiveness DuraGen Plus® Adhesion Barrier Matrix adhesion barrier spinal surgery reduce extent peridural fibrosis formation radicular pain comparison control group receive standard care .</brief_summary>
	<brief_title>DuraGen Plus® Adhesion Barrier Use Spinal Surgery</brief_title>
	<detailed_description>For information , please visit www.DuragenStudy.com</detailed_description>
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Spinal Injuries</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Inclusion Criteria ( Abstracted clinical protocol ) : Patients radicular pain require singlelevel , lumbar hemilaminectomy hemilaminotomy procedure discectomy low lumbar spine Require initial open lumbar surgery extrude , prolapse bulge intervertebral disc Requires removal herniated disc fragment Exclusion Criteria ( Abstracted clinical protocol ) : Current historic open traumatic injury spine Any previous surgery lumbar spine percutaneous tissue destruction ablation procedure Women nursing , woman pregnant woman plan become pregnant time study Any spinal condition systemic disease would preclude patient participation clinical trial Clinically significant structural disorder Known positive HIV Insulindependent Diabetes Mellitus patient Morbid obesity ( Body Mass Index great equal 40 kg/m2 ) History alcohol drug abuse within 2 year prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>